I. Condello: J Extra Corpor Technol 2025, 57, 119--122 121
maintaining organ perfusion. This is crucial in the pre-operative phase to prevent malperfusion syndrome, which can severely impair renal, cerebral, and splanchnic organ function.
1. Cerebral Protection: The brain is highly susceptible to ischemia resulting from compromised blood flow in ATAAD. ECMO facilitates cerebral protection by ensuring adequate cerebral perfusion. This is achieved through the maintenance of systemic blood pressure, which is critical for preventing cerebral ischemia and subsequent neurological deficits. The precise control of blood flow provided by ECMO helps avoid the drastic fluctuations in blood pressure that can exacerbate brain injury, thus safeguarding neurologic function during this vulnerable period [ 1 ].
2. Renal Protection: Renal function can deteriorate rapidly under conditions of low perfusion characteristic of ATAAD. ECMO supports renal function by ensuring continuous renal blood flow. This is vital for filtering metabolic wastes and managing fluid balance, which is critical in preventing acute kidney injury-- a common complication that can significantly extend hospital stays and affect post-operative recovery [ 2 ].
3. Protection of Splanchnic Organs: Splanchnic organs, such as the intestines and liver, require a consistent and high-level blood supply to maintain function. ECMO supports these organs by ensuring adequate blood flow, thus preventing ischemic injuries that could lead to severe complications like mesenteric ischemia. By providing a stable flow and preventing fluctuations in blood pressure, ECMO helps maintain the integrity and function of the gastrointestinal tract and liver, which are crucial for recovery and overall health [ 1 ].
Challenges of implementing VA ECMO in ATAAD
Despite its significant benefits, implementing VA ECMO in ATAAD is fraught with challenges that require meticulous management:
Cannulation Challenges: Proper cannulation is paramount and must be performed with precision to avoid damaging the vessels, particularly in a dissection scenario where the integrity of vascular structures may be compromised. The choice of cannulation sites requires careful consideration and ultrasound-guided techniques may be employed to enhance safety and accuracy. Correct positioning of the cannulas is crucial not only to ensure effective ECMO function but also to minimize the risk of complications such as limb ischemia, vascular injury, and improper perfusion [ 4 ].
Management of Hemodynamics: Balancing the hemodynamic support provided by ECMO without exacerbating the heart’ s workload, especially the left ventricle, necessitates careful adjustment and continuous monitoring [ 10 ]. The aim is to ensure enough perfusion pressure to prevent organ malperfusion while avoiding excessive afterload that could strain the heart, particularly when left ventricular function is already compromised [ 3 ]. Echocardiographic monitoring becomes a valuable tool in this context, providing real-time feedback on cardiac function and ECMO impact [ 10 ]. While specific targets vary, typical mean arterial pressures 65 mmHg and flows to match 60--80 mL / kg / min are often referenced, the role of echocardiography is fundamental in titrating these settings [ 2 ], but further studies are needed to validate these target parameters. This allows for the timely adjustment of ECMO flow and pressure settings to optimize cardiac unloading and minimize myocardial stress.
Systemic Anticoagulation: The need for anticoagulation with ECMO introduces significant risks of bleeding, particularly in the surgical setting where patients are already at a heightened risk due to the invasive nature of their conditions. Managing these risks while maintaining effective anticoagulation to prevent clotting within the ECMO circuit requires a delicate balance. This often involves continuous monitoring of coagulation parameters and individualized adjustments to anticoagulation protocols [ 2 ]. While there are currently no standardized dosage recommendations tailored specifically to VA ECMO use in the setting of acute type A aortic dissection( ATAAD), particularly when employed as a bridge to surgery, aligning clinical decisions with established guidelines and the standard of care remains essential. Following best practice protocols ensures consistency, safety, and efficacy in patient management even in areas where clinical evidence is still evolving. By adhering to expert consensus and institutional protocols derived from broader ECMO experience, clinicians can provide care that is both evidence-informed and adaptable to the nuances of ATAAD. This approach not only supports optimal patient outcomes but also fosters a framework for ongoing evaluation and refinement of ECMO strategies in this complex and high-risk population [ 5 ].
Conclusion
The use of Peripheral VA ECMO in the management of acute ATAAD presents a critical yet debated intervention within cardiovascular care. While ECMO is instrumental in preventing malperfusion and safeguarding organ function, its impact on increasing the myocardial workload invites a complex balance that remains a subject of clinical scrutiny. This juxtaposition underscores ECMO not only as a lifesaving measure but also as a catalyst for ongoing debate regarding its optimal application. Given the dual-edged nature of ECMO, offering profound benefits in preventing organ failure while potentially exacerbating cardiac stress, it is clear that this therapeutic strategy occupies a vital space in the continuum of care for ATAAD. However, the conversation about ECMO’ s role does not end here. It is indeed an open perspective that demands further exploration and understanding. The complexity of ECMO’ s effects on cardiac dynamics, particularly in the context of peripheral cannulation and its associated afterload implications, warrants deeper investigation. Future studies are required to delineate clear guidelines and develop advanced protocols that not only maximize the benefits of ECMO but also mitigate its